Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress

Yogita Dheer1, Nitin Chitranshi2, Veer Gupta3

  • 1Faculty of Medicine and Health Sciences, Macquarie University, F10A, 2 Technology Place, North Ryde, NSW, 2109, Australia. yogitadheer@gmail.com.

Molecular Neurobiology
|April 12, 2018
PubMed

Insights

Bexarotene, a Retinoid X receptor (RXR) agonist, shows neuroprotective effects by increasing RXR expression and reducing amyloid beta toxicity. High doses can cause neurotoxicity, but TrkB receptor targeting may prevent this.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Retinoid X receptors (RXRs) are nuclear receptors investigated for neurodegenerative disorders.
  • Bexarotene, an RXR agonist, demonstrates neuroprotection by enhancing amyloid beta (Aβ) uptake.
  • Dysregulation of RXR expression is implicated in Alzheimer's disease pathology.

Purpose of the Study:

  • To investigate the dose-dependent effects of bexarotene on RXR expression in neuroblastoma cells and mouse brains.
  • To determine if bexarotene can counteract Aβ-induced neurotoxicity.
  • To explore the role of TrkB receptor signaling in bexarotene's downstream effects.

Main Methods:

  • SH-SY5Y neuroblastoma cells and mouse models were treated with varying concentrations of bexarotene.
  • Protein expression of RXR isoforms, ER stress markers, and BAD was analyzed using Western blotting and immunofluorescence.
  • Experiments involved co-treatments with Aβ, TrkB agonist (7,8-dihydroxyflavone), and TrkB inhibitor (CTX-B).

Main Results:

  • Optimal bexarotene concentrations increased RXR α, β, and γ expression in cells and mouse brains.
  • Bexarotene rescued Aβ-induced loss of RXR expression, ER stress, and BAD activation.
  • High bexarotene concentrations induced ER stress and BAD activation, which were mitigated by TrkB receptor activation.

Conclusions:

  • Bexarotene exhibits dose-dependent effects on RXR expression and neuroprotection.
  • Targeting RXRs with bexarotene may offer a therapeutic strategy against Aβ-induced neurotoxicity.
  • TrkB receptor signaling interacts with bexarotene's downstream effects, suggesting a potential mechanism for managing drug toxicity.

Related Concept Videos

Endoplasmic Reticulum01:39

Endoplasmic Reticulum

The Endoplasmic Reticulum (ER) in eukaryotic cells is a substantial network of interconnected membranes with diverse functions, from calcium storage to biomolecule synthesis. A primary component of the endomembrane system, the ER manufactures phospholipids critical for membrane function throughout the cell. Additionally, the two distinct regions of the ER specialize in the manufacture of specific lipids and proteins.
110.8K
The Endoplasmic Reticulum01:43

The Endoplasmic Reticulum

The endoplasmic reticulum or ER makes up for more than half of the membranes in a cell and accounts for 10% of total cell volume. It is also the primary protein and lipid synthesis factory for most cell organelles, such as the Golgi apparatus, lysosomes, secretory vesicles, and the plasma membrane. Despite being the most extensive and functionally complex subcellular organelle, ER was the last to be discovered. After years of deliberation, Keith Porter and George Palade in the year 1954,...
21.7K
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
8.2K
Directing Proteins to the Rough Endoplasmic Reticulum01:34

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
17.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K